Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics
From MaRDI portal
(Redirected from Publication:888654)
Recommendations
- Mathematical modelling of the interaction between cancer cells and an oncolytic virus: insights into the effects of treatment protocols
- The role of viral infectivity in oncolytic virotherapy outcomes: a mathematical study
- Modeling oncolytic virotherapy: is complete tumor-tropism too much of a good thing?
- Enhancing oncolytic virotherapy: observations from a Voronoi cell-based model
- Dynamics of tumor virotherapy: a deterministic and stochastic model approach
Cites work
- A cellular automata model of tumor-immune system interactions
- A cellular automaton model for tumour growth in inhomogeneous environment
- Analysis of a three-way race between tumor growth, a replication-competent virus and an immune response
- Computational modeling approaches to studying the dynamics of oncolytic viruses
- Interactions between the immune system and cancer: A brief review of non-spatial mathematical models
- Modeling of cancer virotherapy with recombinant measles viruses
- ODE models for oncolytic virus dynamics
- Optimization of virotherapy for cancer
Cited in
(20)- Developing a minimally structured mathematical model of cancer treatment with oncolytic viruses and dendritic cell injections
- Oncolytic viral therapies and the delicate balance between virus-macrophage-tumour interactions: a mathematical approach
- Natural killer cells recruitment in oncolytic virotherapy: a mathematical model
- A mathematical model for oncolytic virus spread using the telegraph equation
- A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept
- A mathematical model for tumor growth and treatment using virotherapy
- Hopf bifurcation on a cancer therapy model by oncolytic virus involving the malignancy effect and therapeutic efficacy
- Oncolytic virotherapy for tumours following a Gompertz growth law
- Multiscale modelling of cancer response to oncolytic viral therapy
- Enhancing oncolytic virotherapy: observations from a Voronoi cell-based model
- Oncolytic virus treatment of human breast cancer cells: modelling therapy efficacy
- Mathematical model of tumor-immune surveillance
- Bifurcations and chaotic dynamics in a tumour-immune-virus system
- Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy
- Resistance in oncolytic viral therapy for solid tumors
- Computational modeling of cancer response to oncolytic virotherapy: improving the effectiveness of viral spread and anti tumor efficacy
- Boundedness of the solution to a higher-dimensional triply haptotactic cross-diffusion system modeling oncolytic virotherapy
- Modeling the interaction of cytotoxic T-lymphocytes and oncolytic viruses in a tumor microenvironment
- Assessing the role of model complexity in virtual clinical trial outcomes
- Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections
This page was built for publication: Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q888654)
